Merck & Co. is turning down its option to license Evaxion’s gonorrhea vaccine candidate, closing the door on the Danish biotech’s chance to collect up to $592 million in biobucks. Evaxion will now ...

For the better part of a year, Merck & Co. and Halozyme have been locked in an intellectual property disagreement over the the pharma giant's new, under-the-skin version of cancer megablockbuster ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

NEW YORK CITY, NY / ACCESS Newswire / December 2, 2025 / Merck Sharp & Dohme LLC ("Merck") recently suffered a data breach that compromised the sensitive personal data of individuals. This data breach ...

That term has become the industry shorthand for assuring people nervous about AI’s increasing foothold in healthcare. There’s always someone watching over what AI does. We are there to make sure ...

Merck (MRK)’s stock surged by 41% over the past six months, driven not significantly by revenue, but rather by increased profits and heightened investor confidence. Following crucial Q3 earnings ...

SAN DIEGO (FOX 5/KUSI) — Unionized nurses and health care workers with Sharp HealthCare are set to strike on Nov. 26 following failed contract negotiations. Represented by Sharp Professional Nurses ...

Waseem is a writer here at GameRant. He can still feel the pain of Harry Du Bois in Disco Elysium, the confusion of Alan Wake in the Remedy Connected Universe, the force of Ken's shoryukens and the ...

Preparations for a possible strike against Sharp HealthCare were underway after 97% of nurses voted to authorize it, according to union officials. Members of the Sharp Professional Nurses Network and ...

Merck published its financial results for Q3 2025 this morning. Strong demand for Winrevair from patients suffering from pulmonary arterial hypertension drove sales to $360 million in the third ...

The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of new vaccines. A team of researchers at Purdue University and Merck & Co. Inc.